Richardson Mary K, Ross Ryan C, Kusnezov Nicholas, Vega Andrew N, Ludington John, Longjohn Donald B, Oakes Daniel A, Heckmann Nathanael D
Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
J Arthroplasty. 2024 Mar;39(3):772-777. doi: 10.1016/j.arth.2023.09.033. Epub 2023 Sep 29.
Extensor mechanism disruption is a challenging complication following total knee arthroplasty. The purpose of this study was to compare outcomes between patients who received mesh versus allograft extensor mechanism reconstruction.
All patients who underwent extensor mechanism reconstruction at a single institution were screened. Demographic and surgical variables were recorded, including technique (ie, synthetic mesh versus allograft reconstruction). Patients were assessed for preoperative and postoperative extensor lag, revision, and duration of follow-up. Analyses, including Kaplan-Meier survivorships, were performed to compare mesh to allograft reconstruction. In total, 50 extensor mechanism reconstructions (30 mesh and 20 allograft) were conducted between January 1st, 2001, and December 31st, 2022.
There were no differences between the cohorts with respect to revision (26.7 [8 of 30] versus 35.0% [7 of 20], P = .680) or failure defined as above knee amputation or fusion (6.7 [2 of 30] versus 5.0% [1 of 20], P = .808). There were also no differences in time to reoperation (average 27 months [range, 6.7 to 58.8] versus 29 months [range, 1.2 to 84.9], P = .910) or in postoperative extensor lag among patients who did not undergo a reoperation (13 [0 to 50] versus 11° [0 to 30], P = .921). The estimated 5-year Kaplan-Meier survival with extensor mechanism revision as the endpoint was similar between the 2 groups (52.1, 95% confidence interval [CI] = 25.4 to 73.3 versus 55.0%, 95% CI = 23.0 to 78.4%, P = .990).
The purpose of this study was to present the findings of a large cohort of patients who required extensor mechanism reconstruction. Regardless of the reconstruction type, the 5-year outcomes of patients requiring extensor mechanism reconstruction are suboptimal.
伸肌机制破坏是全膝关节置换术后一种具有挑战性的并发症。本研究的目的是比较接受网片与同种异体移植物伸肌机制重建的患者的结局。
对在单一机构接受伸肌机制重建的所有患者进行筛查。记录人口统计学和手术变量,包括技术(即合成网片与同种异体移植物重建)。评估患者术前和术后的伸肌滞后、翻修情况及随访时间。进行包括Kaplan-Meier生存率分析在内的分析,以比较网片与同种异体移植物重建。2001年1月1日至2022年12月31日期间共进行了50例伸肌机制重建(30例使用网片,20例使用同种异体移植物)。
两组在翻修方面(26.7%[30例中的8例]对35.0%[20例中的7例],P = 0.680)或定义为膝上截肢或融合的失败情况(6.7%[30例中的2例]对5.0%[20例中的1例],P = 0.808)无差异。再次手术时间(平均27个月[范围6.7至58.8个月]对29个月[范围1.2至84.9个月],P = 0.910)或未进行再次手术的患者术后伸肌滞后情况(13°[范围0至50°]对11°[范围0至30°],P = 0.921)也无差异。以伸肌机制翻修为终点的估计5年Kaplan-Meier生存率在两组间相似(52.1%,95%置信区间[CI]=25.4%至73.3%对55.0%,95%CI = 23.0%至78.4%,P = 0.990)。
本研究的目的是展示一大群需要伸肌机制重建的患者的研究结果。无论重建类型如何,需要伸肌机制重建的患者的5年结局都不理想。